文献速递会诊联络精神医学精神分裂症与精神病性障碍心境障碍

既往精神障碍与抗抑郁药使用对新冠结局的多中心研究

The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study.
PubMed 文献 · Mol Psychiatry · 2023-04-17

该回顾性队列研究基于INSIGHT临床研究网络116,498例新冠确诊患者电子健康记录,分析既往精神障碍诊断及抗抑郁药使用与新冠结局的关系。经倾向评分匹配控制人口学与躯体合并症后,既往精神障碍与住院、急性肾衰竭、严重脓毒症及死亡风险增加相关,抗抑郁药使用与脓毒症和死亡风险显著降低相关。

要点

  • 既往精神障碍诊断与新冠住院及后续并发症风险增加相关。
  • 精神分裂症谱系或双相障碍患者死亡风险增加。
  • 抗抑郁药使用与脓毒症和死亡风险显著降低相关。

核心结论

  • 新冠就诊前有精神障碍诊断与更严重的新冠相关结局及后续健康并发症风险增加相关。
  • 有迹象表明抗抑郁药使用可能降低这一风险。

研究设计与样本

  • 回顾性队列研究,评估INSIGHT临床研究网络2020年3月1日至2021年2月23日确诊新冠的116,498例患者电子健康记录。
  • 使用倾向评分匹配控制人口学与躯体合并症后,用列联表评估精神障碍史与抗抑郁药使用同新冠结局的关系。

主要发现

  • 既往精神障碍与住院风险增加相关,并与急性肾衰竭和严重脓毒症等后续结局相关。
  • 精神分裂症谱系障碍或双相障碍患者死亡风险增加。
  • 抗抑郁药使用与脓毒症风险显著降低相关(p = 0.033)。
  • 抗抑郁药使用与死亡风险显著降低相关(p = 0.026)。

关键数值与推荐

  • 新冠相关结局包括住院、插管/机械通气、急性肾衰竭、严重脓毒症和死亡。
  • 抗抑郁药使用与脓毒症风险降低相关,p = 0.033。
  • 抗抑郁药使用与死亡风险降低相关,p = 0.026。

临床怎么用

  • 对新冠患者应关注既往精神障碍史,尤其是精神分裂症谱系或双相障碍,以识别重症高危人群。
  • 抗抑郁药使用与新冠不良结局风险降低相关,可能对治疗和预后有参考意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pre-existing mental disorders are linked to COVID-19-related outcomes. However, the findings are inconsistent and a thorough analysis of a broader spectrum of outcomes such as COVID-19 infection severity, morbidity, and mortality is required. We investigated whether the presence of psychiatric diagnoses and/or the use of antidepressants influenced the severity of the outcome of COVID-19. This retrospective cohort study evaluated electronic health records from the INSIGHT Clinical Research Network in 116,498 individuals who were diagnosed with COVID-19 between March 1, 2020, and February 23, 2021. We examined hospitalization, intubation/mechanical ventilation, acute kidney failure, severe sepsis, and death as COVID-19-related outcomes. After using propensity score matching to control for demographics and medical comorbidities, we used contingency tables to assess whether patients with (1) a history of psychiatric disorders were at higher risk of more severe COVID-19-related outcomes and (2) if use of antidepressants decreased the risk of more severe COVID-19 infection. Pre-existing psychiatric disorders were associated with an increased risk for hospitalization, and subsequent outcomes such as acute kidney failure and severe sepsis, including an increased risk of death in patients with schizophrenia spectrum disorders or bipolar disorders. The use of antidepressants was associated with significantly reduced risk of sepsis (p = 0.033), death (p = 0.026). Psychiatric disorder diagnosis prior to a COVID-19-related healthcare encounter increased the risk of more severe COVID-19-related outcomes as well as subsequent health complications. However, there are indications that the use of antidepressants might decrease this risk. This may have significant implications for the treatment and prognosis of patients with COVID-19.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Schultebraucks K, Blekic W, Basaraba C, et al. The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study. Mol Psychiatry. 2023. PMID: 37069343. doi:10.1038/s41380-023-02049-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。